Micron Technology (MU) Holder United Capital Financial Advisers Has Upped Its Position by $1.03 Million; Penn Davis Mcfarland Maintains Position in Celgene (CELG)

May 21, 2018 - By Maria Brooks

Celgene Corporation (NASDAQ:CELG) Logo

United Capital Financial Advisers Llc increased its stake in Micron Technology Inc (MU) by 14.66% based on its latest 2017Q4 regulatory filing with the SEC. United Capital Financial Advisers Llc bought 25,067 shares as the company’s stock rose 18.77% while stock markets declined. The institutional investor held 196,031 shares of the technology company at the end of 2017Q4, valued at $8.06 million, up from 170,964 at the end of the previous reported quarter. United Capital Financial Advisers Llc who had been investing in Micron Technology Inc for a number of months, seems to be bullish on the $64.30 billion market cap company. The stock increased 3.84% or $2.05 during the last trading session, reaching $55.44. About 62.00 million shares traded or 13.74% up from the average. Micron Technology, Inc. (NASDAQ:MU) has risen 82.20% since May 21, 2017 and is uptrending. It has outperformed by 70.65% the S&P500.

Penn Davis Mcfarland Inc increased its stake in Celgene Corporation (CELG) by 149.89% based on its latest 2017Q4 regulatory filing with the SEC. Penn Davis Mcfarland Inc bought 101,686 shares as the company’s stock declined 19.30% with the market. The institutional investor held 169,526 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $17.69 million, up from 67,840 at the end of the previous reported quarter. Penn Davis Mcfarland Inc who had been investing in Celgene Corporation for a number of months, seems to be bullish on the $54.18B market cap company. The stock decreased 4.81% or $3.77 during the last trading session, reaching $74.6. About 18.46 million shares traded or 159.28% up from the average. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since May 21, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

Investors sentiment decreased to 1.24 in 2017 Q4. Its down 0.13, from 1.37 in 2017Q3. It turned negative, as 49 investors sold MU shares while 245 reduced holdings. 126 funds opened positions while 239 raised stakes. 883.15 million shares or 0.40% less from 886.67 million shares in 2017Q3 were reported. Regent Invest Mgmt Ltd Liability Corporation invested in 0.6% or 44,415 shares. Rhumbline Advisers reported 1.94M shares. Ivory Inv Mgmt Limited Liability reported 1.94 million shares. Art Advisors Ltd Liability Corp stated it has 260,700 shares. Friess Associates Lc accumulated 1.59% or 467,645 shares. First Foundation accumulated 38,770 shares or 0.09% of the stock. The North Carolina-based Captrust has invested 0% in Micron Technology, Inc. (NASDAQ:MU). Jefferies Group Limited Liability Company has 1.47 million shares. Sentinel Com Lba holds 75,201 shares. Dnb Asset Management As stated it has 1.3% in Micron Technology, Inc. (NASDAQ:MU). Tci Wealth reported 100 shares. Moreover, Commonwealth Of Pennsylvania Public School Empls Retrmt has 0.06% invested in Micron Technology, Inc. (NASDAQ:MU). Moreover, Federated Invsts Pa has 0.01% invested in Micron Technology, Inc. (NASDAQ:MU) for 77,858 shares. Senator Investment Gru Ltd Partnership reported 3.22M shares. Adage Ptnrs Grp Ltd has invested 0.15% in Micron Technology, Inc. (NASDAQ:MU).

More notable recent Micron Technology, Inc. (NASDAQ:MU) news were published by: Globenewswire.com which released: “Micron Technology to Present at Bernstein Strategic Decisions Conference 2018” on May 17, 2018, also Seekingalpha.com with their article: “The Market Is Doubtful Of Micron” published on May 10, 2018, Seekingalpha.com published: “Micron: Shorts Are Scared To Act” on May 16, 2018. More interesting news about Micron Technology, Inc. (NASDAQ:MU) were released by: Finance.Yahoo.com and their article: “Monday’s Vital Data: Apple Inc. (AAPL), Micron Technology, Inc. (MU) and Netflix, Inc. (NFLX)” published on April 30, 2018 as well as Seekingalpha.com‘s news article titled: “Micron: Reading The Tea Leaves” with publication date: May 14, 2018.

Among 43 analysts covering Micron Technology Inc. (NASDAQ:MU), 35 have Buy rating, 1 Sell and 7 Hold. Therefore 81% are positive. Micron Technology Inc. had 242 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Buy” rating by Cowen & Co given on Wednesday, September 27. The firm has “Buy” rating given on Wednesday, October 11 by Summit Redstone Partners. The stock of Micron Technology, Inc. (NASDAQ:MU) earned “Buy” rating by Mizuho on Friday, March 23. Stifel Nicolaus maintained Micron Technology, Inc. (NASDAQ:MU) on Thursday, October 19 with “Buy” rating. As per Thursday, December 17, the company rating was upgraded by Morgan Stanley. The rating was maintained by Goldman Sachs on Thursday, January 11 with “Buy”. The firm has “Buy” rating given on Wednesday, September 27 by Robert W. Baird. The firm earned “Buy” rating on Thursday, September 7 by Needham. Needham maintained the shares of MU in report on Friday, June 30 with “Buy” rating. The firm has “Buy” rating given on Tuesday, September 29 by Stifel Nicolaus.

United Capital Financial Advisers Llc, which manages about $9.56B and $12.67B US Long portfolio, decreased its stake in Mcdonald’s Corp. (NYSE:MCD) by 52,365 shares to 195,046 shares, valued at $33.76M in 2017Q4, according to the filing. It also reduced its holding in Yum! Brands Inc. (NYSE:YUM) by 4,420 shares in the quarter, leaving it with 151,622 shares, and cut its stake in Ishares Msci Australia (EWA).

Since January 2, 2018, it had 0 insider buys, and 13 sales for $7.65 million activity. Another trade for 3,000 shares valued at $129,520 was made by BAILEY ROBERT L on Thursday, February 1. Another trade for 50,000 shares valued at $2.17 million was made by Mondry Lawrence N on Wednesday, February 14. On Tuesday, May 8 the insider Thorsen Steven L. JR sold $1.36M. $31,814 worth of Micron Technology, Inc. (NASDAQ:MU) was sold by ARNZEN APRIL S. On Wednesday, February 7 Deboer Scott J sold $638,380 worth of Micron Technology, Inc. (NASDAQ:MU) or 14,750 shares. Another trade for 14,360 shares valued at $665,058 was sold by Byrne Patrick J.

Investors sentiment decreased to 0.83 in Q4 2017. Its down 0.34, from 1.17 in 2017Q3. It dived, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. Tru Investment reported 0.45% stake. Fdx Advisors stated it has 0.07% in Celgene Corporation (NASDAQ:CELG). Arrowmark Colorado Hldg Lc has invested 0.19% in Celgene Corporation (NASDAQ:CELG). Hugh Johnson Advsrs Ltd has 21,500 shares for 0.66% of their portfolio. 38,815 were reported by Sumitomo Life Insur Comm. Redmile Gp Lc reported 653,000 shares. Ashford Management has invested 0.09% in Celgene Corporation (NASDAQ:CELG). Qs Invsts Ltd Llc owns 79,845 shares or 0.08% of their US portfolio. Central Financial Bank Trust Com holds 1.48% or 58,614 shares in its portfolio. Natl Bank Of Mellon Corp stated it has 0.24% in Celgene Corporation (NASDAQ:CELG). Toth Advisory has 485 shares. Koshinski Asset holds 16,147 shares. Brighton Jones Limited Liability Corp holds 0.1% or 7,639 shares in its portfolio. Budros Ruhlin & Roe holds 0.1% or 3,543 shares in its portfolio. Somerville Kurt F reported 0.1% of its portfolio in Celgene Corporation (NASDAQ:CELG).

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Schaeffersresearch.com which released: “3 Biotech Stocks Bucking the Broad-Market Surge” on May 21, 2018, also Seekingalpha.com with their article: “Celgene’s (CELG) Management Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript)” published on May 16, 2018, Seekingalpha.com published: “Should The FDA Be Shaming Drug Companies? Financial Advisors’ Daily Digest” on May 21, 2018. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: Investorplace.com and their article: “5 Top Stock Trades for Tuesday Morning” published on May 21, 2018 as well as Seekingalpha.com‘s news article titled: “Generic Revlimid Could Sink Celgene” with publication date: May 16, 2018.

Among 35 analysts covering Celgene Corporation (NASDAQ:CELG), 20 have Buy rating, 1 Sell and 14 Hold. Therefore 57% are positive. Celgene Corporation had 146 analyst reports since July 21, 2015 according to SRatingsIntel. RBC Capital Markets maintained Celgene Corporation (NASDAQ:CELG) on Friday, January 29 with “Outperform” rating. Oppenheimer maintained Celgene Corporation (NASDAQ:CELG) rating on Monday, October 30. Oppenheimer has “Outperform” rating and $166 target. On Monday, January 8 the stock rating was maintained by Credit Suisse with “Buy”. The company was initiated on Tuesday, November 8 by Mizuho. SunTrust maintained it with “Buy” rating and $156.0 target in Friday, October 20 report. The firm has “Hold” rating given on Friday, May 5 by Argus Research. The stock of Celgene Corporation (NASDAQ:CELG) has “Equal-Weight” rating given on Friday, October 20 by Barclays Capital. The stock of Celgene Corporation (NASDAQ:CELG) has “Buy” rating given on Thursday, September 14 by Jefferies. The rating was maintained by RBC Capital Markets on Wednesday, October 4 with “Buy”. The stock of Celgene Corporation (NASDAQ:CELG) earned “Overweight” rating by JP Morgan on Wednesday, March 21.

Since February 8, 2018, it had 1 insider purchase, and 3 insider sales for $3.58 million activity. Alles Mark J bought $299,594 worth of stock or 3,260 shares. On Monday, March 12 LOUGHLIN JAMES J sold $851,093 worth of Celgene Corporation (NASDAQ:CELG) or 9,250 shares. Another trade for 13,370 shares valued at $1.26 million was made by MARIO ERNEST on Friday, February 23.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Maria Brooks

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: